Close Menu
Home » For Lab Industry, FDA Draft Guidance on NGS Testing Inseparable From Larger LDT Debate

For Lab Industry, FDA Draft Guidance on NGS Testing Inseparable From Larger LDT Debate

Jul 11, 2016
|
Turna Ray
Premium

NEW YORK (GenomeWeb) – After releasing white papers, holding several public workshops, and listening to stakeholder feedback, the US Food and Drug Administration has released two draft guidances outlining how it might review the analytical and clinical validity of next-generation sequencing tests.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

That Rude Reviewer

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

New FDA Commish Confirmed

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

DNA Screening for Apple Employees

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

Science Studies Describe Role for Microbiome-Derived Immunity, Platform to Develop Flavivirus Vaccines

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Sequencing

  1. Twist Bioscience Teases Products for Liquid Biopsy Market, Biopharma Collaborations

    Premium

  2. Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

    Premium

  3. Abu Dhabi Teams Up With BGI, Oxford Nanopore for Population Sequencing Project

  4. Online Tool to Select Secondary Findings May Shorten Genetic Counseling Sessions

  5. Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.